If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
217.00    6.50 (3.09%)
Bid:
218.00
Ask:
218.50
Spread: 0.50 (0.229%)
Market Cap: £577.50m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

27 Apr 2026 12:27

RNS Number : 0638C
Costain Group PLC
27 April 2026
 

 

 

Costain Group PLC (the 'Company')

27 April 2026

 

Scrip Dividend Reference Price

 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the final dividend for the year ending 31 December 2025 is 187.36 pence per ordinary share.

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 16 April 2026.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the final dividend for the year ending 31 December 2025 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 7 May 2025.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any further documentation to receive this scrip dividend.

The final dividend for the year ending 31 December 2025, including the scrip dividend, will be paid on 26 May 2026 (the dividend payment date), subject to approval at the 2026 Annual General Meeting on 14 May 2026, to the ordinary shareholders of the Company on the register at close of business on 17 April 2026 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

 

Enquiries

 

Investors and analysts

Matt Jones, Costain

matt.jones@costain.com

+44 (0)7860 922341

 

Company Secretariat

Katie Mullins, Costain

Cyd Trumper, Costain

costaincosec@costain.com

+44 (0)20 3922 0600

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997365

Charlie Twigg

+44 (0) 7946 494568

 

 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVZZGZDMNKGVZM
Date   Source Headline
31st Jan 20189:00 amRNSTotal Voting Rights
11th Jan 201812:32 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSYear End Trading Update
2nd Jan 20188:00 amRNSTotal Voting Rights
2nd Jan 20188:00 amRNSBlock listing Interim Review
18th Dec 201711:50 amRNSHolding(s) in Company
14th Dec 20177:00 amRNSManagement Consultancy Framework Appointment
8th Dec 20178:00 amRNSDirector/PDMR Shareholding
30th Nov 20178:00 amRNSTotal Voting Rights
28th Nov 20173:18 pmRNSHolding(s) in Company
24th Nov 201711:28 amRNSBoard Notification - External Directorship
23rd Nov 20172:48 pmRNSHolding(s) in Company
17th Nov 201710:13 amRNSAppointment of Non Executive Director
1st Nov 201711:21 amRNSDirector/PDMR Shareholding
1st Nov 201711:16 amRNSTotal Voting Rights
26th Oct 20177:00 amRNSBlock Listing Application
25th Oct 20172:22 pmRNSDirector/PDMR Shareholding
20th Oct 20173:42 pmRNSHolding(s) in Company
17th Oct 20177:00 amRNSDividend - Scrip Alternative
29th Sep 20177:00 amRNSGreater Manchester Waste contract
25th Sep 20172:21 pmRNSDirector/PDMR Shareholding
21st Sep 201710:10 amRNSScrip Dividend Reference Price
15th Sep 20179:39 amRNSHolding(s) in Company
4th Sep 201710:37 amRNSHolding(s) in Company
24th Aug 20177:00 amRNSGreater Manchester Waste contract
23rd Aug 20177:00 amRNSHalf-year Report
1st Aug 20177:00 amRNSContract
20th Jul 20178:45 amRNSHolding(s) in Company
17th Jul 20178:12 amRNSHigh Speed Two "minded to award" Costain contracts
13th Jul 201712:19 pmRNSRe: Directorate
4th Jul 20177:00 amRNSTrading Update
30th Jun 20179:00 amRNSBlock listing Interim Review
31st May 201712:00 pmRNSTotal Voting Rights
16th May 20177:00 amRNSDividend - Scrip Alternative
8th May 20174:55 pmRNSResult of AGM
8th May 20177:00 amRNSAGM Statement
2nd May 20174:37 pmRNSGreater Manchester Waste contract
28th Apr 20171:56 pmRNSTotal Voting Rights
26th Apr 20175:06 pmRNSHolding(s) in Company
13th Apr 201710:52 amRNSScrip Dividend Reference Price
6th Apr 20179:40 amRNSDirector/PDMR Shareholding
5th Apr 201710:02 amRNSHolding(s) in Company
4th Apr 20174:16 pmRNSHolding(s) in Company
3rd Apr 20173:41 pmRNSHolding(s) in Company
31st Mar 201710:07 amRNSTotal Voting Rights
24th Mar 20179:28 amRNSHolding(s) in Company
20th Mar 201712:22 pmRNSHolding(s) in Company
17th Mar 20177:00 amRNSNotice of AGM
14th Mar 20172:30 pmRNSHolding(s) in Company
13th Mar 201712:12 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.